Latest News

Pharma imports into the US increased in March, as drugmakers sought to avoid tariffs

Imports of pharmaceuticals into the U.S. soared in March, as drugmakers stockpiled ahead of possible U.S. tariffs. Their products have been historically exempted from such fees.

The U.S. Commerce Department reported on Tuesday that total imports of pharmaceuticals products in August exceeded $50 billion. This is the equivalent of 20 percent of all pharmaceutical imports by 2024.

Ireland, which is the largest drug exporter in the U.S., saw a significant increase in imports. In March, the country's trade surplus with the U.S. was greater than China for the first.

Drugs accounted for the majority of the increase in imports from Ireland, which rose to $15.5 billion between February and March.

Matthew Martin, senior U.S. economic analyst at Oxford Economics wrote that the report revealed pharmaceutical products to be $20 billion more expensive. "Almost all of these were imported from Ireland", he added.

As part of his trade policy, President Donald Trump is threatening to increase tariffs on medicines.

The Trump administration began a probe last month into the imports of pharmaceuticals in anticipation of possible tariffs based on the argument that a heavy reliance on foreign medicine production is a threat to national security.

Trump announced on Monday that he will make an announcement about the tariffs within the next two week. Trump also issued an Executive Order aimed at lessening the regulatory burden for drug production in the U.S.

Drugmakers have taken unusual steps to prepare for tariffs, including increasing their efforts to stock up on medicines.

On a conference call, Pfizer CEO Albert Bourla stated, "You can imagine that we've done everything we could to mitigate the risk, which includes inventory and many other things." He said that the company increased its inventory every month to ensure "we are well-positioned."

Merck's main exposure comes from the blockbuster cancer medicine Keytruda. It is the world's most popular prescription drug, and is manufactured in Ireland. Last month, the company announced that it had shipped enough inventory to America to cover it until year's end.

Oxford's Martin says that in addition to Ireland and the other European Union nations, Singapore and Switzerland are also at high risk of the proposed drug import levies.

(source: Reuters)